Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Biopharmaceuticals Market Report 2016

  • QYR694087
  • 123 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Biopharmaceuticals

Revenue, means the sales value of Biopharmaceuticals

This report studies sales (consumption) of Biopharmaceuticals in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Abbott Laboratories

Amgen

Astrazeneca

BASF

Bayer

Biocon

Biogen Idec

Boehringer Ingelheim

Bristol-Myers Squibb

Daiichi Sankyo

Eli Lilly and Company

Genentech

Glaxosmithkline

Hospira

Johnson & Johnson

LG Life Sciences

Novartis

Novo Nordisk

Pfizer

Ranbaxy Laboratories

Roche Holding

Sanofi

Takeda Pharmaceutical Company

Teva Pharmaceutical Industries

UCB

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Biopharmaceuticals in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States Biopharmaceuticals Market Report 2016

1 Biopharmaceuticals Overview

1.1 Product Overview and Scope of Biopharmaceuticals

1.2 Classification of Biopharmaceuticals

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Biopharmaceuticals

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Biopharmaceuticals (2011-2021)

1.4.1 USA Biopharmaceuticals Sales and Growth Rate (2011-2021)

1.4.2 USA Biopharmaceuticals Revenue and Growth Rate (2011-2021)

2 USA Biopharmaceuticals Competition by Manufacturers

2.1 USA Biopharmaceuticals Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Biopharmaceuticals Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Biopharmaceuticals Average Price by Manufactures (2015 and 2016)

2.4 Biopharmaceuticals Market Competitive Situation and Trends

2.4.1 Biopharmaceuticals Market Concentration Rate

2.4.2 Biopharmaceuticals Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Biopharmaceuticals Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Biopharmaceuticals Sales and Market Share by Type (2011-2016)

3.2 USA Biopharmaceuticals Revenue and Market Share by Type (2011-2016)

3.3 USA Biopharmaceuticals Price by Type (2011-2016)

3.4 USA Biopharmaceuticals Sales Growth Rate by Type (2011-2016)

4 USA Biopharmaceuticals Sales (Volume) by Application (2011-2016)

4.1 USA Biopharmaceuticals Sales and Market Share by Application (2011-2016)

4.2 USA Biopharmaceuticals Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Biopharmaceuticals Manufacturers Profiles/Analysis

5.1 Abbott Laboratories

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Biopharmaceuticals Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Abbott Laboratories Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Amgen

5.2.2 Biopharmaceuticals Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Amgen Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Astrazeneca

5.3.2 Biopharmaceuticals Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Astrazeneca Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 BASF

5.4.2 Biopharmaceuticals Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 BASF Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Bayer

5.5.2 Biopharmaceuticals Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Bayer Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Biocon

5.6.2 Biopharmaceuticals Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Biocon Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Biogen Idec

5.7.2 Biopharmaceuticals Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Biogen Idec Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Boehringer Ingelheim

5.8.2 Biopharmaceuticals Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Boehringer Ingelheim Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Bristol-Myers Squibb

5.9.2 Biopharmaceuticals Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Bristol-Myers Squibb Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Daiichi Sankyo

5.10.2 Biopharmaceuticals Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Daiichi Sankyo Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Eli Lilly and Company

5.12 Genentech

5.13 Glaxosmithkline

5.14 Hospira

5.15 Johnson & Johnson

5.16 LG Life Sciences

5.17 Novartis

5.18 Novo Nordisk

5.19 Pfizer

5.20 Ranbaxy Laboratories

5.21 Roche Holding

5.22 Sanofi

5.23 Takeda Pharmaceutical Company

5.24 Teva Pharmaceutical Industries

5.25 UCB

6 Biopharmaceuticals Manufacturing Cost Analysis

6.1 Biopharmaceuticals Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Biopharmaceuticals

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Biopharmaceuticals Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Biopharmaceuticals Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Biopharmaceuticals Market Forecast (2016-2021)

10.1 USA Biopharmaceuticals Sales, Revenue Forecast (2016-2021)

10.2 USA Biopharmaceuticals Sales Forecast by Type (2016-2021)

10.3 USA Biopharmaceuticals Sales Forecast by Application (2016-2021)

10.4 Biopharmaceuticals Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Biopharmaceuticals

Table Classification of Biopharmaceuticals

Figure USA Sales Market Share of Biopharmaceuticals by Type in 2015

Table Application of Biopharmaceuticals

Figure USA Sales Market Share of Biopharmaceuticals by Application in 2015

Figure USA Biopharmaceuticals Sales and Growth Rate (2011-2021)

Figure USA Biopharmaceuticals Revenue and Growth Rate (2011-2021)

Table USA Biopharmaceuticals Sales of Key Manufacturers (2015 and 2016)

Table USA Biopharmaceuticals Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Biopharmaceuticals Sales Share by Manufacturers

Figure 2016 Biopharmaceuticals Sales Share by Manufacturers

Table USA Biopharmaceuticals Revenue by Manufacturers (2015 and 2016)

Table USA Biopharmaceuticals Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Biopharmaceuticals Revenue Share by Manufacturers

Table 2016 USA Biopharmaceuticals Revenue Share by Manufacturers

Table USA Market Biopharmaceuticals Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Biopharmaceuticals Average Price of Key Manufacturers in 2015

Figure Biopharmaceuticals Market Share of Top 3 Manufacturers

Figure Biopharmaceuticals Market Share of Top 5 Manufacturers

Table USA Biopharmaceuticals Sales by Type (2011-2016)

Table USA Biopharmaceuticals Sales Share by Type (2011-2016)

Figure USA Biopharmaceuticals Sales Market Share by Type in 2015

Table USA Biopharmaceuticals Revenue and Market Share by Type (2011-2016)

Table USA Biopharmaceuticals Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Biopharmaceuticals by Type (2011-2016)

Table USA Biopharmaceuticals Price by Type (2011-2016)

Figure USA Biopharmaceuticals Sales Growth Rate by Type (2011-2016)

Table USA Biopharmaceuticals Sales by Application (2011-2016)

Table USA Biopharmaceuticals Sales Market Share by Application (2011-2016)

Figure USA Biopharmaceuticals Sales Market Share by Application in 2015

Table USA Biopharmaceuticals Sales Growth Rate by Application (2011-2016)

Figure USA Biopharmaceuticals Sales Growth Rate by Application (2011-2016)

Table Abbott Laboratories Basic Information List

Table Abbott Laboratories Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Abbott Laboratories Biopharmaceuticals Sales Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amgen Biopharmaceuticals Sales Market Share (2011-2016)

Table Astrazeneca Basic Information List

Table Astrazeneca Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Astrazeneca Biopharmaceuticals Sales Market Share (2011-2016)

Table BASF Basic Information List

Table BASF Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table BASF Biopharmaceuticals Sales Market Share (2011-2016)

Table Bayer Basic Information List

Table Bayer Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer Biopharmaceuticals Sales Market Share (2011-2016)

Table Biocon Basic Information List

Table Biocon Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Biocon Biopharmaceuticals Sales Market Share (2011-2016)

Table Biogen Idec Basic Information List

Table Biogen Idec Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Biogen Idec Biopharmaceuticals Sales Market Share (2011-2016)

Table Boehringer Ingelheim Basic Information List

Table Boehringer Ingelheim Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Boehringer Ingelheim Biopharmaceuticals Sales Market Share (2011-2016)

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bristol-Myers Squibb Biopharmaceuticals Sales Market Share (2011-2016)

Table Daiichi Sankyo Basic Information List

Table Daiichi Sankyo Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Daiichi Sankyo Biopharmaceuticals Sales Market Share (2011-2016)

Table Eli Lilly and Company Basic Information List

Table Eli Lilly and Company Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly and Company Biopharmaceuticals Sales Market Share (2011-2016)

Table Genentech Basic Information List

Table Genentech Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genentech Biopharmaceuticals Sales Market Share (2011-2016)

Table Glaxosmithkline Basic Information List

Table Glaxosmithkline Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Glaxosmithkline Biopharmaceuticals Sales Market Share (2011-2016)

Table Hospira Basic Information List

Table Hospira Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Hospira Biopharmaceuticals Sales Market Share (2011-2016)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Johnson & Johnson Biopharmaceuticals Sales Market Share (2011-2016)

Table LG Life Sciences Basic Information List

Table LG Life Sciences Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table LG Life Sciences Biopharmaceuticals Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Biopharmaceuticals Sales Market Share (2011-2016)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novo Nordisk Biopharmaceuticals Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Biopharmaceuticals Sales Market Share (2011-2016)

Table Ranbaxy Laboratories Basic Information List

Table Ranbaxy Laboratories Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ranbaxy Laboratories Biopharmaceuticals Sales Market Share (2011-2016)

Table Roche Holding Basic Information List

Table Roche Holding Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Roche Holding Biopharmaceuticals Sales Market Share (2011-2016)

Table Sanofi Basic Information List

Table Sanofi Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi Biopharmaceuticals Sales Market Share (2011-2016)

Table Takeda Pharmaceutical Company Basic Information List

Table Takeda Pharmaceutical Company Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Takeda Pharmaceutical Company Biopharmaceuticals Sales Market Share (2011-2016)

Table Teva Pharmaceutical Industries Basic Information List

Table Teva Pharmaceutical Industries Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table Teva Pharmaceutical Industries Biopharmaceuticals Sales Market Share (2011-2016)

Table UCB Basic Information List

Table UCB Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)

Table UCB Biopharmaceuticals Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Biopharmaceuticals

Figure Manufacturing Process Analysis of Biopharmaceuticals

Figure Biopharmaceuticals Industrial Chain Analysis

Table Raw Materials Sources of Biopharmaceuticals Major Manufacturers in 2015

Table Major Buyers of Biopharmaceuticals

Table Distributors/Traders List

Figure USA Biopharmaceuticals Production and Growth Rate Forecast (2016-2021)

Figure USA Biopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)

Table USA Biopharmaceuticals Production Forecast by Type (2016-2021)

Table USA Biopharmaceuticals Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370